MetaCap

Virax Biolabs Group (VRAX) News

NASDAQ: VRAXHealth CareBiotechnology: In Vitro & In Vivo Diagnostic SubstancesUSD

0.3319-0.0491 (-12.89%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

VRAX news summary

We found 1 recent headline mentioning Virax Biolabs Group (VRAX): 0 in the past week and 1 in the past 30 days, most often from PR Newswire. VRAX is making an outsized move today, down 12.89% at $0.3319, which often coincides with company-specific news. Check the latest headlines below for the likely catalyst. The most recent story, "Virax Biolabs Appoints Three Distributors for ImmuneSelect Research Products in Mainland China", was published by PR Newswire on Oct 29, 2026.

Headlines link to the original publishers. MetaCap does not republish third-party articles.

Summary generated from market data by MetaCap's automated system. Methodology

Latest Virax Biolabs Group headlines

Compare VRAX